11 results
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
and Management Initiative ... Medications: ... Agent, Initiation ... #Pain #Pharmacology ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... Non-Opioid Analgesics - Agents ... #Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... Muscle Relaxants - Agents ... #Pain #Pharmacology ... Relaxers #Relaxants #Medications ... #Doses #Dosing
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... #diabetes #medications ... #table #comparison ... #management #endocrinology ... #dm2
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... #pharmacology #pharmacotherapy ... #table #comparison ... #management #medications ... #diabetes #endocrinology
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... Distribution, Agents ... #Pain #Pharmacology ... Nerve #Blocks #Medications ... #Doses #Dosing
Antidepressant Medications Decision Aid
 - The choice of depression medications in primary care is difficult as
best evidence does ... mostly across agents ... #Management #PatientInfo ... Antidepressants #Comparison ... SNRIs #Selection #Pharmacology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
different than other medications ... very tolerable medication ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Diabetes #Mellitus #DM2 ... #pharmacology # ... comparison #table ... #endocrinology
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Pain Assessment ... - Agents and Dosing ... #Management # ... Pain #Pharmacology ... #Doses #Dosing